NCT06481241View on ClinicalTrials.gov

Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

NARecruitingINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2028

Conditions
Philadelphia Chromosome Negative ALLAcute Lymphoblastic Leukemia, Adult
Interventions
COMBINATION_PRODUCT

CAR-T cells

CAR-T cells as consolidation therapy

DRUG

Venetoclax

VEN

Trial Locations (1)

300020

RECRUITING

Institute of Hematology & Blood Diseases Hospital, Tianjin

All Listed Sponsors
lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER